<code id='CBBC9DCB7E'></code><style id='CBBC9DCB7E'></style>
    • <acronym id='CBBC9DCB7E'></acronym>
      <center id='CBBC9DCB7E'><center id='CBBC9DCB7E'><tfoot id='CBBC9DCB7E'></tfoot></center><abbr id='CBBC9DCB7E'><dir id='CBBC9DCB7E'><tfoot id='CBBC9DCB7E'></tfoot><noframes id='CBBC9DCB7E'>

    • <optgroup id='CBBC9DCB7E'><strike id='CBBC9DCB7E'><sup id='CBBC9DCB7E'></sup></strike><code id='CBBC9DCB7E'></code></optgroup>
        1. <b id='CBBC9DCB7E'><label id='CBBC9DCB7E'><select id='CBBC9DCB7E'><dt id='CBBC9DCB7E'><span id='CBBC9DCB7E'></span></dt></select></label></b><u id='CBBC9DCB7E'></u>
          <i id='CBBC9DCB7E'><strike id='CBBC9DCB7E'><tt id='CBBC9DCB7E'><pre id='CBBC9DCB7E'></pre></tt></strike></i>

          fashion

          fashion

          author:hotspot    Page View:498
          Two Vertex buidings in the Seaport District
          David L Ryan/Globe Staff

          When Vertex Pharmaceuticals moved from Cambridge to Boston’s Seaport a decade ago, it signaled that what was then a sea of parking lots could be a booming business district, and galvanized a wave of new development.

          Now, Vertex may be on the move again.

          advertisement

          With the lease on its two-building campus on Fan Pier set to expire in 2028, the company is reevaluating its real estate options — and considering leaving its prominent headquarters for another spot in the neighborhood.

          Get unlimited access to award-winning journalism and exclusive events.

          Subscribe Log In

          focus

          At least 13 dead in Texas as scorching temps continue
          At least 13 dead in Texas as scorching temps continue

          1:17FirefighterEMTWilliamDorseyandfirefighterEMTRodrigoPinedatreatamigrantwomansufferingfromheatexha

          read more
          Amid AI frenzy, a top HHS official's quest to create safeguards
          Amid AI frenzy, a top HHS official's quest to create safeguards

          MickyTripathiOfficeoftheNationalCoordinatorforHealthInformationTechnologyMickyTripathiisequalpartsex

          read more
          BioMarin wins approval for gene therapy to treat hemophilia A
          BioMarin wins approval for gene therapy to treat hemophilia A

          AdobeTheFoodandDrugAdministrationonThursdayapprovedagenetherapytotreatpeoplewithhemophiliaA,aninheri

          read more

          Organ aging and disease risk measured by new blood test

          AdobeIntoday’smostlyplague-andfamine-freeworld,ifyoucanavoidmoremodernscourgeslikegunandcarviolence,